Skip to main content
OpenTrials
Completed

NCT Number: NCT01679015

Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes

Evaluating the percentage of patients that suffer from eye allergies and determining whether they also have dry eyes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dry Eyes Allergic Conjunctivitis Conjunctival Diseases Conjunctivitis Conjunctivitis, Allergic Dry Eye Syndromes Eye Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lacrimal Apparatus Diseases Nervous System Diseases Neurologic Manifestations Paresthesia Pathological Conditions, Signs and Symptoms Pruritus Sensation Disorders Signs and Symptoms Skin Diseases Skin Manifestations Skin and Connective Tissue Diseases Somatosensory Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Schwartz Laser Eye Center

Scottsdale, Arizona, 85260, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ability to give informed consent
  • Males and females at least 18 years of age
  • Personal history of allergic disorders including but not limited to allergic conjunctivitis, allergic rhinitis, contact dermatitis and other eczema, and asthma
  • Diagnosis of allergic conjunctivitis
  • Presence of any of the following signs including conjunctival redness and papillae, chemosis, red edematous eyelids, reduced tear clearance, reduced TBUT, vital staining, stringy discharge, and/or symptoms including ocular itching, burning and tearing, runny nose or itchy throat

Exclusion criteria

  • Active ocular or systemic infection
  • History of ocular infection within past 6 months
  • Presence of punctal plugs
  • Recent ocular surgery within past 6 months
  • Current use of chemotherapeutic agents
  • Presence of ocular trauma
  • Inability to give informed consent
  • Women who are pregnant, nursing or lactating

Treatment and study plan

Primary outcomes

  1. Prevalence of dry eye in an allergic population presenting to a high volume optometry practice

    Time frame: up to 2 years

Secondary outcomes

  1. Prevalence of allergic patients with moderate to severe ocular signs and symptoms

    Time frame: up to 2 years

Sponsors and collaborators

Lead sponsor

Schwartz Laser Eye Center

Other

Collaborators

  • Allergan

Registry information

Official study title

Concomitant Dry Eye in Patients With Ocular Allergy: an Under Recognized and Poorly Managed Syndrome

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Sep 5, 2012
Registry last updated
Jun 3, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.